We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


GE Healthcare Launches FTA® DMPK Cards for Storage of Preclinical and Clinical Study Samples

Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "GE Healthcare Launches FTA® DMPK Cards for Storage of Preclinical and Clinical Study Samples"

First Name*
Last Name*
Email Address*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

GE Healthcare announces the launch of FTA® DMPK cards for the collection and storage of blood samples for use in pharmacokinetic and toxicokinetic (PK/TK) studies. This methodology stores the samples as dried blood spots (DBS) and has a broad applicability across the entire drug discovery and development process, from research through to preclinical and clinical trials.

The lower required blood volumes of 10 to 20 µl, compared to traditional approaches needing up to 500 µl, supports serial sampling, leading to enhanced data consistency and a reduction in the number of animals required per study.

FTA DMPK cards deliver both an ethical and economic benefit with workflow time reduced, as the procedure for blood sample processing is simplified.

For all card types the resultant DBS samples can be stored and shipped at room temperature whilst FTA DMPK-A and FTA DMPK-B cards also inactivate viruses and prevent bacterial contamination. Therefore, handling and shipping of samples is safer.

For analysis, sample discs are taken from the cards using a manual or automatic punch, from which the compounds of interest are extracted and analyzed. FTA DMPK cards are now routinely used by pharma and contract research organizations.